STOCKSCREENR

TLRY

NASDAQ

Tilray Brands, Inc.

$6.16-0.08(-1.28%)Mkt Cap: $736.76M

Key Stats

Market Cap

$736.76M

P/E Ratio

-0.42

EPS

$-14.63

Dividend Yield

0.00%

52-Week Range

$3.50 — $23.20

Volume

4.08M

Avg Volume

4.25M

Beta

2.11

Price Alerts for TLRY

Get alerted when TLRY hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.42

Forward P/E

—

PEG Ratio

-0.01

P/S (TTM)

0.68

P/B (TTM)

0.47

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.92%

ROA (TTM)

-0.89%

ROIC

—

Gross Margin

0.28%

Operating Margin

-1.83%

Net Margin

—

Debt/Equity

0.14

Current Ratio

2.79

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-2.49%

EPS Growth (5Y)

-1.44%

Sales Growth (3Y)

+0.13%

Sales Growth (5Y)

+0.24%

EPS Est (This Year)

$-0.48

EPS Est (Next Year)

$-0.27

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.95

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

116.23M

Float

115.60M

Free Float %

99.46%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

CA

Exchange

NASDAQ

IPO Date

2018-07-19

Employees

2650

CEO

Irwin David Simon

Index Membership

—

Website

https://www.tilray.com

Tilray Brands, Inc. (TLRY) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $736.76M, a P/E ratio of -0.42, TLRY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare TLRY against other stocks using dozens of fundamental and technical filters.

Similar Stocks

EMBC

Embecta Corp.

$9.23

+0.87%

$546.60M

AMPH

Amphastar Pharmaceuticals, Inc.

$21.88

-0.36%

$974.43M

EOLS

Evolus, Inc.

$5.33

-1.11%

$346.77M

LOVE.V

Cannara Biotech Inc.

$1.89

+6.18%

$181.03M

ORGO

Organogenesis Holdings Inc.

$2.57

+9.36%

$330.61M

HCM

HUTCHMED (China) Limited

$13.30

-1.04%

$2.32B

Frequently Asked Questions

What is Tilray Brands, Inc.'s P/E ratio?

Tilray Brands, Inc. (TLRY) has a trailing twelve-month (TTM) P/E ratio of -0.42. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Tilray Brands, Inc. pay a dividend?

No, Tilray Brands, Inc. (TLRY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Tilray Brands, Inc.'s market cap?

Tilray Brands, Inc. (TLRY) has a market capitalization of $736.76 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.